www.dmx.eis-deliveryintegration.cloud Open in urlscan Pro
15.197.241.190  Public Scan

Form analysis
1 forms found in the DOM

.

<form class="sc-gGvHcT eovP sc-bhhwZE iKnifw" action="." role="search">
  <div class="sc-GhhNo hoJqoc sc-fIzWTo bmUEpP" data-element="autocomplete-wrapper">
    <div role="combobox" aria-haspopup="listbox" aria-owns="react-autowhatever-1" aria-expanded="false" class="react-autosuggest__container">
      <div class="sc-ilhmMj ecEDiA sc-ckEbSK eYfQSX react-autosuggest__input" data-element="input-text"><input id="autosuggest" name="search" placeholder="Search" type="text" data-element="autocomplete" autocomplete="off" aria-autocomplete="list"
          aria-controls="react-autowhatever-1" aria-label="search" class="sc-hHTYSt sc-gYbzsP gIXoiW kVKlQP" value="" style="border-top-left-radius: 0px; border-bottom-left-radius: 0px;"><span aria-label="Clear" role="button" tabindex="0"
          data-auto="cancel" class="sc-cCjUiG bhNBPU"><svg class="sc-jSUZER kHascC sc-cjibBx cRkEoQ" viewBox="0 0 24 24" aria-hidden="true" role="presentation" focusable="false">
            <path
              d="M12 2C6.47 2 2 6.47 2 12s4.47 10 10 10 10-4.47 10-10S17.53 2 12 2zm4.3 14.3c-.39.39-1.02.39-1.41 0L12 13.41 9.11 16.3c-.39.39-1.02.39-1.41 0-.39-.39-.39-1.02 0-1.41L10.59 12 7.7 9.11c-.39-.39-.39-1.02 0-1.41.39-.39 1.02-.39 1.41 0L12 10.59l2.89-2.89c.39-.39 1.02-.39 1.41 0 .39.39.39 1.02 0 1.41L13.41 12l2.89 2.89c.38.38.38 1.02 0 1.41z">
            </path>
          </svg></span></div><button class="sc-ehvNnt cNDNOJ sc-fbYMXx jhVRig" type="submit" aria-label="search" data-element="autocomplete-search-button"><svg class="sc-jSUZER WnfJO sc-laZRCg ktxSnf" viewBox="0 0 24 24" aria-hidden="true"
          role="presentation" focusable="false">
          <path d="M15.5 14h-.79l-.28-.27A6.47 6.47 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z"></path>
        </svg></button>
      <div id="react-autowhatever-1" role="listbox" class="react-autosuggest__suggestions-container"></div>
    </div>
  </div>
</form>

Text Content

You need to enable JavaScript to run this app. Please click here to perform a
System Check
 * Specialties
 * Alerts
 * Drugs A–Z
 * Drug Interactions
 * IV Compatibility
 * NeoFax Peds
 * Patient Info
 * Calculators
 * EBM

Unlock full access to evidence-based medical guidance.
Sign inSubscribe
Or, sign up for a FREE Trial

CME
 * Specialties
 * Alerts
 * Drugs A–Z
 * Drug Interactions
 * IV Compatibility
 * NeoFax Peds
 * Patient Info
 * Calculators
 * EBM

English
ČeštinaEspañolDeutschEnglishFrançaisItalianoNederlandsNorskPortuguêsРусскийSuomiSvenska中文日本語한국어



RECENT ALERTS

Follow your specialty and individual topics to personalize alerts. 

All

--------------------------------------------------------------------------------

Potentially Practice-Changing Only
EvidenceUpdated 27 Jun 2024

National Institute for Health and Care Excellence (NICE) guideline on voxelotor
for treating haemolytic anaemia caused by sickle cell disease can be found at
(NICE 2024 Jun 12:TA981)

View in Sickle Cell Disease in Adults and Adolescents

Drug/Device AlertUpdated 21 Jun 2024

dapagliflozin (Farxiga) receives expanded FDA approval as an adjunct to diet and
exercise to improve glycemic control in patients ≥ 10 years old with type 2
diabetes mellitus (FDA Product Information 2024 Jun)

View in Diabetes Mellitus Type 2 in Children and Adolescents

Subscribe to personalize your alerts. Already subscribed? Sign in.

EvidenceUpdated 21 Jun 2024

breast massage by physical therapist with or without therapeutic ultrasound may
reduce severity of breast engorgement immediately after treatment in lactating
individuals with breast symptoms (BMC Pregnancy Childbirth 2023 Nov 14)

View in Breastfeeding

EvidenceUpdated 21 Jun 2024

renin-angiotensin system inhibitors may reduce cardiovascular risks in non-Black
patients with HFrEF but not in Black patients with HFrEF (JAMA 2024 May 29 early
online)

View in Angiotensin-Converting Enzyme (ACE) Inhibitors for Heart Failure

EvidenceUpdated 20 Jun 2024

addition of atezolizumab to carboplatin- or cisplatin-based chemotherapy as
first-line treatment may improve progression-free survival but not overall
survival in adults with locally advanced or metastatic urothelial carcinoma
(Lancet Oncol 2024 Jan)

View in Management of Metastatic Bladder Cancer

Guideline SummaryUpdated 20 Jun 2024

National Comprehensive Cancer Network (NCCN) recommendations on management of
metastatic breast cancer (NCCN 2024 Mar)

View in Management of Metastatic Breast Cancer

Guideline SummaryUpdated 20 Jun 2024

American Society of Clinical Oncology (ASCO) recommendations on hormone receptor
(HR) positive, HER2 negative metastatic breast cancer (ASCO 2024 Feb)

View in Management of Metastatic Breast Cancer

Guideline SummaryUpdated 20 Jun 2024

European Society for Medical Oncology (ESMO) recommendations on metastatic
breast cancer (ESMO 2023 May)

View in Management of Metastatic Breast Cancer

EvidenceUpdated 20 Jun 2024

addition of stereotactic body radiation therapy (SBRT) to systemic therapy may
not improve overall survival or slow down disease progression in adults with
metastatic breast cancer who have oligoprogression after ≥ 1 line of systemic
therapy (Lancet 2024 Jan 13)

View in Management of Metastatic Breast Cancer

EvidenceUpdated 20 Jun 2024

SBRT reported to have 3-year overall survival of 52% in adults with lung and/or
liver oligometastases from breast cancer (Radiother Oncol 2024 Jun)

View in Management of Metastatic Breast Cancer

View All Alerts

Unlock full access to evidence-based medical guidance.
Sign inSubscribe
Or, sign up for a FREE Trial


DYNAMED DECISIONS

DynaMed Decisions offers evidence-based clinical decision support and shared
decision-making tools

Try a FREE tool:

Breast Cancer Screening

Personalized guidance for breast cancer risk assessment and screening
recommendations. Includes age-based risk visualization and patient decision aid.




ANNOUNCEMENTS


OMICRON: WHAT THE DATA REVEALS

Amidst rampant speculation about the widespread COVID-19 variant, we answer five
important questions about Omicron using the latest evidence. Read the Health
Notes blog post


NEW THYROID NODULE DIAGNOSIS ALGORITHM

Thyroid nodules may be caused by benign or malignant lesions. We offer a new
algorithm offering a stepwise approach to diagnosis: Thyroid Nodule Diagnosis
Algorithm (PDF)

Read our full topic: Thyroid Nodules


SPECIALTIES

Browse and follow our evidence-driven and continually updated topics by
specialty.

Browse Specialties



DRUG RESOURCES

In addition to NeoFax® / Pediatrics, we offer:

Drugs A-Z

Drug monographs from Merative Micromedex®.

Drug Interaction Checker

Learn how two or more drugs interact and keep your patients safe.

IV Compatibility



GO MOBILE



Our iOS & Android apps are FREE for use by all subscribers.

Get the App

 * About
 * Mobile
 * System Check
 * Help
 * Privacy Policy
 * Terms of Use
 * Copyright
 * Manage Cookies


© 2024 EBSCO Industries, Inc. All rights reserved.
Feedback

top